SYT8 and cancer: While the roles of SYT8 and TNNI2 have not been broadly described in the context of cancer, their expression levels have been shown to be increased in gastric and bladder-related cancers, indicating that SYT8 and TNNI2 could act as prognostic markers [14–16].